[go: up one dir, main page]

Bilenki et al., 2006 - Google Patents

Adoptive transfer of CD8α+ dendritic cells (DC) isolated from mice infected with Chlamydia muridarum are more potent in inducing protective immunity than CD8α …

Bilenki et al., 2006

View PDF
Document ID
8734925140129341103
Author
Bilenki L
Wang S
Yang J
Fan Y
Jiao L
Joyee A
Han X
Yang X
Publication year
Publication venue
The Journal of Immunology

External Links

Snippet

Chlamydial infections are serious public health concerns worldwide. In this study, we examined the role of dendritic cell (DC) subsets in inducing protective immunity against chlamydial infection using an adoptive transfer approach. We found that CD11c+ …
Continue reading at www.academia.edu (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature

Similar Documents

Publication Publication Date Title
Joyee et al. Distinct NKT cell subsets are induced by different Chlamydia species leading to differential adaptive immunity and host resistance to the infections
O’Connell et al. Plasmid-deficient Chlamydia muridarum fail to induce immune pathology and protect against oviduct disease
Jiao et al. NK cells promote type 1 T cell immunity through modulating the function of dendritic cells during intracellular bacterial infection
Farkas et al. Plasmacytoid dendritic cells (natural interferon-α/β-producing cells) accumulate in cutaneous lupus erythematosus lesions
Bilenki et al. NK T cell activation promotes Chlamydia trachomatis infection in vivo
Ellison et al. Murine graft-versus-host disease in an F1-hybrid model using IFN-γ gene knockout donors
Bilenki et al. Adoptive transfer of CD8α+ dendritic cells (DC) isolated from mice infected with Chlamydia muridarum are more potent in inducing protective immunity than CD8α− DC
Edwan et al. Flt-3 ligand reverses late allergic response and airway hyper-responsiveness in a mouse model of allergic inflammation
Yang Role of cytokines in Chlamydia trachomatis protective immunity and immunopathology
Alabraba et al. Coculture of human liver macrophages and cholangiocytes leads to CD40‐dependent apoptosis and cytokine secretion
Mukherjee et al. Surfactant protein A integrates activation signal strength to differentially modulate T cell proliferation
Stinn et al. Interferon-γ-secreting T-cell populations in rejecting murine cardiac allografts: assessment by flow cytometry
Otsuka et al. Achaete-scute homologue 2–regulated follicular helper T cells promote autoimmunity in a murine model for sjögren syndrome
Thomas et al. Semaphorin 3E protects against chlamydial infection by modulating dendritic cell functions
US20040259790A1 (en) Methods for identifying and administering agents that bias the immune response via dendritic cells
JP3502229B2 (en) Recombinant eukaryotic cell plasmid containing allergen gene and its use for prevention and / or treatment of allergic diseases
Curry et al. Reactivity of resident immunocytes in normal and prepsoriatic skin using an ex vivo skin-explant model system
Osorio et al. CD8+-dependent CNS demyelination following ocular infection of mice with a recombinant HSV-1 expressing murine IL-2
Paz et al. Neuropilin-2, the specific binding partner to ATYR1923, is expressed in sarcoid granulomas and key immune cells
Kopitar et al. Specific T cell responses to Helicobacter pylori predict successful eradication therapy
Séguier et al. Immunohistologic and morphometric analysis of cytotoxic T lymphocytes in gingivitis
Beatty et al. Cross-reactive cytotoxic T-lymphocyte-mediated lysis of Chlamydia trachomatis-and Chlamydia psittaci-infected cells
AU2004241513A1 (en) Method of screening inhibitor by using induction of interleukin 18 production by keratinocyte, method of inducing atopic dermatitis-like symptom and utilization of the same
Marsh et al. Studies of intestinal lymphoid tissue: X-observations on granular epithelial lymphocytes (gEL) in normal and diseased human jejunum
Lingel et al. Prenatal antibiotics exposure does not influence experimental allergic asthma in mice